March 29, 2018 / 1:34 PM / 4 months ago

BRIEF-Jilin Province Huinan Changlong Bio-Pharmacy Co Says FY Revenue RMB645.3 Mln

Reuters Staff

1 Min Read

March 29 (Reuters) - Jilin Province Huinan Changlong Bio-Pharmacy Co Ltd:

* FY REVENUE RMB645.3 MILLION VERSUS RMB654.1 MILLION

* FY ‍PROFIT ATTRIBUTABLE RMB144.4 MILLION VERSUS RMB142.7 MILLION Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below